| Stage | ACN | % of rev | CTSH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $18.7B | 100.00% | $5.7B | 100.00% | ACN ×3.30 |
| Gross profit | $6.0B | 32.04% | $1.9B | 33.77% | CTSH +1.7pp |
| Operating income | $2.9B | 15.33% | $872M | 15.40% | CTSH +0.1pp |
| Pre-tax income | $2.8B | 14.98% | $863M | 15.24% | CTSH +0.3pp |
| Net income | $2.0B | 10.89% | $627M | 11.07% | CTSH +0.2pp |
| Stage | ACN | CTSH | Gap · A − B |
|---|---|---|---|
| Revenue | $18.7B100.00% | $5.7B100.00% | ACN ×3.30 |
| Gross profit | 32.04%$6.0B | 33.77%$1.9B | CTSH +1.7pp |
| Operating income | 15.33%$2.9B | 15.40%$872M | CTSH +0.1pp |
| Pre-tax income | 14.98%$2.8B | 15.24%$863M | CTSH +0.3pp |
| Net income |
| 10.89%$2.0B |
| 11.07%$627M |
| CTSH +0.2pp |